But the study is not peer-reviewed, and three doctors who spoke with Fortune raised concerns about it being unclear on its methods, inclusion and exclusion criteria, other medications or surgeries that may not be accounted for, and whether participants continued a planned diet and exercise regimen post-medication
Related Research Comparisons Choosing Between Retatrutide and Tirzepatide for Research When comparing Retatrutide vs Tirzepatide, researchers typically consider the complexity of receptor interaction required for their experimental model
While liraglutide and semaglutide work through the same GLP-1 receptor pathway, they differ in how long they act, how often theyre taken, and what theyre approved to treat
For detailed comparison, see the tirzepatide vs retatrutide guide
Zepbound, an FDA-approved dual GLP-1 and GIP receptor agonist for chronic weight management, can produce significant results, but plateaus lasting 4-8 weeks are normal physiological responses
doi: 10.1038/s41392-024-01931-z